Component-Resolved Evaluation of the Risk and Success of Immunotherapy in Bee Venom Allergic Patients.

J Clin Med · 2022 · PMC8950594 · PMID 35330002

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendp = 0.07so close (0.05 < p ≤ 0.1)

Patients with allergic side effects during the entire course of VIT showed a trend towards higher rApi m 5 values when compared to the group without allergic side effects: median [Q25–Q75] 0.41 [0.01–1.12] vs. 0.04 [0–0.50] p = 0.07 ( Table 7 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.